Equity
MEDIBRAS paid out €26,145 in dividends. That is 81% of the 2025 profit.
MEDIBRAS paid out €26,145 in dividends. That is 81% of the 2025 profit.
The last five annual accounts were filed 5 to 40 days before the end of the period.
Higher solvency than 88% of companies in human health. Sector median 63.0% · 21,347 companies.
In July 2024, 31,389 companies had the same profile as MEDIBRAS has now. Each dot stands for 79 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,389 companies, not a prediction for MEDIBRAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| MEDIBRAS Nivelles | €183,086 | €60,293 | 92.9% | - |
| Dr. An Konings Kalmthout | €177,320 | €64,294 | 70.8% | - |
| WeeRomGoe Hamme (Vl.) | €185,705 | €63,736 | 69.0% | - |
| DOCTEUR THIERRY BERNARD Watermael-Boitsfort | €210,703 | €59,406 | 53.8% | - |
| CABINET MEDICAL VINCENT MOMIN Waterloo | €164,755 | €57,864 | 78.0% | - |
| CABINET MEDICAL JEAN-PIERRE DEVAUX Genappe | €165,566 | €68,999 | 85.3% | - |
| CABINET MEDICAL DU DOCTEUR CROCHELET Pont-à-Celles | €218,911 | €57,980 | 90.7% | - |
These companies have the same main activity as MEDIBRAS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €165,000 and €219,000, founded between 2004 and 2009.
MEDIBRAS files the micro format. That format states no turnover. The gross margin rose from €8,607 in 2007 to €60,293 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.